Event:
On Feb 19, 08, Tasly Pharmaceutical’s board of directors adopted a stock options incentive scheme (draft), which mainly includes:
...
Comments:
The share incentive scheme is another major move following the management incentive mechanism introduced around listing. We have reasons to believe this will help improve corporate governance and enhance management efficiency further to retain senior management and realize a steady growth of earnings.
Management will be retained in the interests of Tasly Pharmaceutical in the long run.
High management efficiency gave rise to stable earnings growth with few major products in recent years.
The share incentive scheme shows the company’s desire for steady earnings growth.
Major products sales grew stably while powder injection sales were achieved step by step as planned.
Potential risks.
Earnings forecast and rating.